Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer

Detalles Bibliográficos
Autores principales: Gravina, Giovanni Luca, Mancini, Andrea, Colapietro, Alessandro, Marampon, Francesco, Sferra, Roberta, Pompili, Simona, Biordi, Leda Assunta, Iorio, Roberto, Flati, Vincenzo, Argueta, Christian, Landesman, Yosef, Kauffman, Michael, Shacham, Sharon, Festuccia, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824873/
https://www.ncbi.nlm.nih.gov/pubmed/31695847
http://dx.doi.org/10.18632/oncotarget.27289
_version_ 1783464820367949824
author Gravina, Giovanni Luca
Mancini, Andrea
Colapietro, Alessandro
Marampon, Francesco
Sferra, Roberta
Pompili, Simona
Biordi, Leda Assunta
Iorio, Roberto
Flati, Vincenzo
Argueta, Christian
Landesman, Yosef
Kauffman, Michael
Shacham, Sharon
Festuccia, Claudio
author_facet Gravina, Giovanni Luca
Mancini, Andrea
Colapietro, Alessandro
Marampon, Francesco
Sferra, Roberta
Pompili, Simona
Biordi, Leda Assunta
Iorio, Roberto
Flati, Vincenzo
Argueta, Christian
Landesman, Yosef
Kauffman, Michael
Shacham, Sharon
Festuccia, Claudio
author_sort Gravina, Giovanni Luca
collection PubMed
description
format Online
Article
Text
id pubmed-6824873
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-68248732019-11-06 Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer Gravina, Giovanni Luca Mancini, Andrea Colapietro, Alessandro Marampon, Francesco Sferra, Roberta Pompili, Simona Biordi, Leda Assunta Iorio, Roberto Flati, Vincenzo Argueta, Christian Landesman, Yosef Kauffman, Michael Shacham, Sharon Festuccia, Claudio Oncotarget Correction Impact Journals LLC 2019-10-29 /pmc/articles/PMC6824873/ /pubmed/31695847 http://dx.doi.org/10.18632/oncotarget.27289 Text en Copyright: © 2019 Gravina et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Gravina, Giovanni Luca
Mancini, Andrea
Colapietro, Alessandro
Marampon, Francesco
Sferra, Roberta
Pompili, Simona
Biordi, Leda Assunta
Iorio, Roberto
Flati, Vincenzo
Argueta, Christian
Landesman, Yosef
Kauffman, Michael
Shacham, Sharon
Festuccia, Claudio
Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
title Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
title_full Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
title_fullStr Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
title_full_unstemmed Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
title_short Correction: Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
title_sort correction: pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824873/
https://www.ncbi.nlm.nih.gov/pubmed/31695847
http://dx.doi.org/10.18632/oncotarget.27289
work_keys_str_mv AT gravinagiovanniluca correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT manciniandrea correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT colapietroalessandro correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT maramponfrancesco correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT sferraroberta correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT pompilisimona correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT biordiledaassunta correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT iorioroberto correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT flativincenzo correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT arguetachristian correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT landesmanyosef correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT kauffmanmichael correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT shachamsharon correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer
AT festucciaclaudio correctionpharmacologicaltreatmentwithinhibitorsofnuclearexportenhancestheantitumoractivityofdocetaxelinhumanprostatecancer